Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine Responses

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.16.549249Source: DataRank Database

Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine Responses is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (31)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (15)

Julie Baillet ORCID,Maria V. Filsinger Interrante ORCID,Julia Z. Adamska ORCID,Xueting Zhou ORCID,Olivia M. Saouaf ORCID

Live enrichment

PubMed:37577608 OpenAlex:https://openalex.org/W4385459504

National Institutes of Health

Grant: 1P01AI167966-01

Structure-based design of broadly protective coronavirus vaccines

National Institutes of Health

Grant: 5F30AI152943-02

Characterization of the human antibody response to a novel neutralizing HIV-1 epitope

National Institutes of Health

Grant: 5T32GM008412-25

Graduate Training Program in Biotechnology

National Institutes of Health

Grant: 1S10RR013039-01

MICROPLATE SCINTILLATION/LUMINESCENCE/FLOUR COUNTER

National Institutes of Health

Grant: 5T32GM007365-23

MEDICAL SCIENTIST TRAINING PROGRAM

National Institutes of Health

Grant: 7S10OD021600-02

Acquisition of a 300 kV Electron Microscope for Structural Biology

National Institutes of Health

Grant: 1S10RR027431-01

BD Canto II RUO Cytometer

National Institutes of Health

Grant: 1S10OD028697-01

500 MHz NMR Spectrometer System with High Sensitivity Cryoprobe and Automated Sample Changer for Biochemical Research

greenLicense: http://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (http://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2024/06/27/2023.07.16.549249.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.07.16.549249

repositoryhttp://dx.doi.org/10.1101/2023.07.16.549249

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37577608

Fields of Study

Immune Response and InflammationInfluenza Virus Research StudiesImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

AdjuvantVaccine adjuvantImmune systemSaponinAntigenToll-like receptorCytokineMedicineImmunologyBiologyInnate immune systemAIDS VaccinesCOVID-19 VaccinesSARS-CoV-2COVID-19SaponinsMiceAdjuvants, ImmunologicToll-Like Receptor AgonistsAnimalsHumansCytokinesNanoparticlesBiomedicine and Life SciencesAdjuvants, Vaccine

Sustainable Development Goals

SDG 0: Good health and well-being

Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine Responses

FAIR Checklist

DataRank Breakdown

Authors (15)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)